Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Share-based Compensation (2016 - 2025)

Medicure has reported Share-based Compensation over the past 13 years, most recently at $25098.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 32.58% year-over-year to $25098.0; the TTM value through Dec 2025 reached $97270.6, down 32.09%, while the annual FY2025 figure was $97523.7, 30.49% down from the prior year.
  • Share-based Compensation for Q4 2025 was $25098.0 at Medicure, down from $25432.2 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $68319.2 in Q3 2021 and troughed at -$40460.1 in Q4 2021.
  • A 5-year average of $31845.4 and a median of $34249.7 in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: tumbled 167.62% in 2021 and later soared 2625.88% in 2023.
  • Year by year, Share-based Compensation stood at -$40460.1 in 2021, then soared by 94.54% to -$2210.1 in 2022, then soared by 2625.88% to $55824.7 in 2023, then plummeted by 33.32% to $37224.2 in 2024, then crashed by 32.58% to $25098.0 in 2025.
  • Business Quant data shows Share-based Compensation for MCUJF at $25098.0 in Q4 2025, $25432.2 in Q3 2025, and $21651.4 in Q2 2025.